Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > One on One with Investors: Pitch Strategy Discourse with Nanobiotechnology Experts

Abstract:
The Center of Innovation for Nanobiotechnolgy (COIN) announced today that they will be hosting a new offering―a private pitch and strategy coaching session with a team of seasoned investors―at the 2011 North Carolina Nanotechnology Commercialization Conference (NCNCC). Interested participants can sign up for a 30-minute slot with experts to pitch their business and technology, receiving feedback and guidance in addressing tough questions. Slots are offered to registered NCNCC attendees on the afternoon of March 29th from 2 until 5 PM. Grant Thornton LLP generously sponsored this event.

One on One with Investors: Pitch Strategy Discourse with Nanobiotechnology Experts

Durham, NC | Posted on March 16th, 2011

This offering is part of NCNCC, a day-and-a-half conference that is organized by NC Commerce, is in its 3rd year and typically draws approximately 300+ leading nanobiotech and nanotech experts from industry and academia to address key commercialization issues. Nanomedicine entrepreneurs face significant challenges in building their business and developing inventions into marketable platform technology or products. This new dedicated "One on One with Investors: Pitch Strategy Discourse with Experts" offering will be a significant value-add for the conference, helping companies overcome stumbling blocks before they approach investors.



"No entrepreneur wants to be stuck in the starting gate simply because potential customers don't understand or value their product," said John Hardin, Executive Director of NC Commerce's Office of Science and Technology. "Discourse like what these sessions will offer is critical for helping entrepreneurs understand what appeals to the market and how best to position their products to maximize sales. I expect many of the entrepreneurs will consider these sessions to be some of the most valuable 30 minutes they spend in the course of taking their product to market."

COIN is working with NC Commerce to increase the nanomedicine track of the NCNCC, and this "One on One with Investors: Pitch Strategy Discourse with Experts" offering will be one of several new elements that will debut at the 2011 conference. In addition to the pitch sessions, COIN will offer an add-on workshop the morning of March 29th titled: "Actionable Strategies for Company Building and Moving to Market."



Pitch sessions will be held March 29, 2011 from 2-5 PM. This offering is open to any registered attendee of NCNCC. The pitch room is for all NCNCC attendees, not just nanobio/nanomedicine participants. Conference attendees can sign up for a 30-minute slot with experts to make their funding presentation detailing their company or new venture's business and technology and receive feedback and help answering the tough questions. Participating experts include: Bill Warner from Paladin Associates, Nick Wachtel from Lux Capital, Mike Elliot from Noro Moseley, Joe Velk from Contender Capital and Rob Tyler of Poyner Spruill. The cost to participants is included in NCNCC registration. To reserve these coveted spaces, please email: with the title "NCNCC One on One Request".

####

For more information, please click here

Contacts:
Dr. Laura Faulconer

Director, Innovation Projects

The Venable Center, 303 South Roxboro St., Suite 30

Durham, NC 27701



Office: (919) 680-2070 ext 301

Copyright © The Center of Innovation for Nanobiotechnolgy (COIN)

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

180 Degree Capital Corp. to Provide Live Remote Access to Its Annual Meeting of Shareholders on June 12, 2018 June 12th, 2018

180 Degree Capital Corp. Reports Net Asset Value per Share of $2.60 as of December 31, 2017; A Decrease of 3.0% From Prior Quarter and an Increase of 11.1% From December 31, 2016 February 27th, 2018

Nanowire LED Innovator Aledia Announces 30 ($36M) Million Series-C Financing: Intel Capital Joins Existing Investors to Commercialize Certain Nanowire-LED Technologies for Mobile Displays January 29th, 2018

180 Degree Capital Corp. Leads Investment in TheStreet, Inc.; Investment Enables Removal of Capital Structure Overhang November 14th, 2017

Announcements

Searching for errors in the quantum world September 21st, 2018

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

UT engineers develop first method for controlling nanomotors: Breakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Events/Classes

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

Arrowhead Pharmaceuticals to Present at Upcoming September 2018 Conferences August 31st, 2018

Stress-free ALD from Picosun August 28th, 2018

Kavli Lectures: New vision of nanomaterial synthesis and light-fueled space travel August 8th, 2018

Nanobiotechnology

Viral RNA sensing: Optical detection of picomolar concentrations of RNA using switches in plasmonic chirality September 21st, 2018

Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018 September 20th, 2018

NUS researchers invent new test kit for quick, accurate and low-cost screening of diseases: Test results are denoted by a color change and could be further analyzed by a smartphone app, making it attractive as a point-of-care diagnostic device September 19th, 2018

Researchers develop microbubble scrubber to destroy dangerous biofilms September 19th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project